TCTR20240319006尚未招募不适用
Pharmacokinetics of intravenous tigecycline in pediatric patients
Ratchadapisek Sompoch Research Fund0 个研究点目标入组 12 人开始时间: 2024年3月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 1 Months 至 8 Years（—）
- 性别
- All
入选标准
- •1. Patients aged 1 month to 8 years on the day of enrollment
- •2. Receiving intravenous tigecycline at least 6 doses prescribed by their primary physicians for treating MDROs infection
- •3. Adequate vascular access to enable blood collection
排除标准
- •1. Body weight of less than 3 kg
- •2. Tetracycline or tigecycline allergy
- •3.Patients with a Child-Pugh Score class C, which requires an adjustment to the tigecycline dosage
研究者
相似试验
进行中（未招募）
1 期
Pharmacokinetics of Tigecycline in Patients Receiving Continuous Renal Replacement TherapySurgical ICU patients with severe infection and renal replacement therapyEUCTR2012-005617-39-DEniversity Hospital Tuebingen16
暂停
不适用
Prospective study on plasma levels of tigecyclin in septic patients dependent on liver funtion measured by plasma disappearance rate of indocyanine greeA41.9Sepsis, unspecifiedDRKS00007145niversitätsklinikum Jena - Klinik für Anästhesiologie und Intensivtherapie25
Unknown
不适用
Population Pharmacokinetics of Tigecycline in Patients Treated With ECMOExtracorporeal Membrane OxygenationPharmacokineticsTigecyclineNCT04724798Nanfang Hospital, Southern Medical University10
招募中
不适用
Clinical efficacy analysis of drug use tigecycline for re-creation of antimicrobial agents for treatment of Scrub typhus.Certain infectious and parasitic diseasesKCT0007947Inha University Hospital40
已完成
不适用
Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)DiarrheaClostridium DifficileNCT01401023Gary E. Stein, Pharm.D.10